ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,639.50
40.50 (2.53%)
22 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  40.50 2.53% 1,639.50 1,640.50 1,641.50 1,647.50 1,610.50 1,618.00 7,019,136 16:35:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.71 67.56B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,599p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £67.56 billion. Gsk has a price to earnings ratio (PE ratio) of 13.71.

Gsk Share Discussion Threads

Showing 32726 to 32749 of 33100 messages
Chat Pages: Latest  1312  1311  1310  1309  1308  1307  1306  1305  1304  1303  1302  1301  Older
DateSubjectAuthorDiscuss
02/11/2023
14:09
perhaps if they post terrible results the share price will go through the roof. ftse up over 100 points and this is obviously being kicked about.
supermarky
02/11/2023
13:46
#Monty, I have a few of those and look at the FTSE portfolio as an annuity, what it cranks out in dividends is what matters, take them to live on or roll them all back in again and grow the PF for free.. :o)
laurence llewelyn binliner
02/11/2023
13:44
Next we are back down!!!
mj19
02/11/2023
13:40
One minute the vaccines business going forward is biggest growth area. And the stock is undervalued
mj19
02/11/2023
10:54
Sorry boys made a mistake I said shareprice below what it was 30 years ago, it's 37 years ago, I just treat this as a bond with a low yield, compared to what you can get.
montyhedge
02/11/2023
10:19
Seems to be GSK specific???

Very strange as only news today is good news - It is still very early days, but GSK’s respiratory syncytial virus (RSV) Arexvy seems to have flown out of the traps more quickly than Pfizer’s rival shot Abrysvo in the first weeks since they reached the market.

alphorn
02/11/2023
10:19
Terrible is the only word for this
mj19
02/11/2023
10:17
right in the wallet..
lippy4
02/11/2023
10:02
This is very painful
panache1
02/11/2023
09:40
Almost 1500 around 24hrs ago and now sub 1400!!

Having got back in recently at 1430ish I will add slowly but was thinking about taking a quick profit at the open yesterday!!

Good luck all 👍🏻

tuftymatt
02/11/2023
09:37
JP Morgan reiterate its Sell rating. The target price is increased from GBX 1300 to GBX 1400.
hjs
02/11/2023
09:24
Will be on a single digit multiple soon
spoole5
02/11/2023
09:23
has this share got covid???
lippy4
02/11/2023
09:22
.... and a 'buy' reccomendation in today's Tempus column, albeit a rather lukewarm one.
zho
02/11/2023
09:13
Oh dear, yes and it flies in the face of an outstanding set of Q3 results.... :0(
tradermichael
02/11/2023
09:07
Wow what a drop it continues
mj19
02/11/2023
08:40
A bond issued by a third world country?!
spoole5
02/11/2023
08:15
I treat GSK as a bond, shareprice way below what it was when they took over Smith Kline Beecham, but use to get 6% dividend so ok we put up with management.So no growth in shareprice for 30 years absolutely awful. I can't see things changing.
montyhedge
01/11/2023
21:37
It's simple maths here.....divi of c 4% and sfa about it in today's update is a downer in a market where you can get 5-6% safe treasuries/money market funds. Emma needs to get her priorities right-otherwise this could drift to £12 to make the yield competitive, and the market needs to see sustained growth before trusting GSK again
cumnor
01/11/2023
15:46
Whats happened in the past is no presdent what might happen over the next 20 years...
igoe104
01/11/2023
15:38
You can't have this share for capital growth, shareprice below what it was 30 years ago, no growth, but for income good payer.
montyhedge
01/11/2023
14:37
Days range is over a pound lol. This flipping share..
rikky72
01/11/2023
13:54
I still think this close positive today. Great day of profits for MM
beergut
01/11/2023
13:31
HiTaking each of your points:- Dividend isn't one of the best out there at about 4%, but personally not an issue as not an income seeker, it's capital appreciation I'm interested in.- Growth, I assume you meant earnings, well they've just upgraded to a median of +18.5%, which is very impressive given current macros- Chart, well that's all in the eye of the beholder and subjective interpretation depending on your investment criteria. Personally yes I look at the chart for entry/exit signals but overall it's the value, the fundamentals that are key.With their revised guidance this is now on a FY23 PE of 8.5x, the median for the UK pharma industry is 20.7x- Zantac overhang, yeah there could be but show me a pharma that hasn't got similar risks, all part of the industry they are in.Anyway for the record I'm not a holder currently but it is on my ever growing watch list.I note that you trash a lot of companys on here so perhaps you could point me to any stocks you hold that may be viable investments rather than rubbish as I don't normally short.Thanks
disc0dave46
Chat Pages: Latest  1312  1311  1310  1309  1308  1307  1306  1305  1304  1303  1302  1301  Older

Your Recent History

Delayed Upgrade Clock